Welcome to the Kids' Library!

Block, Report, and Suspend Suspicious Shipments Act : report (to accompany H.R. 501).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2023] 2023

Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee

United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2003. 2003

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

Cocaine : crack and powder sentencing disparities

Sacco, Lisa N., author.
[Washington, D.C.] : Congressional Research Service, 2021- 2021

Committee report on license revocation & management control systems :

[Washington, D.C.] : U.S. Dept. of Justice, Drug Enforcement Administration, 1987. 1987

Committee report on scheduling of controlled substances, precursors, chemicals and controlled substa

[Washington, D.C.] : U.S. Dept. of Justice, Drug Enforcement Administration, 1987. 1987

Compilation of selected acts within the jurisdiction of the Committee on Energy and Commerce. includ

United States.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., 2001- 2000

Counterfeit Drug Penalty Enhancement Act of 2012 report (to accompany H.R. 3668) (including cost est

United States. Congress. House. Committee on the Judiciary.
[Washington, D.C.] : [U.S. G.P.O.], [2012] 2012

Counterfeit Drug Penalty Enhancement Act of 2012 : report (to accompany H.R. 3668) (including cost e

United States. Congress. House. Committee on the Judiciary.
[Washington, D.C. : U.S. G.P.O., 2012] 2012

Creating Hope Reauthorization Act : report (to accompany H.R. 4439).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020] 2020

Debarment Enforcement of Bad Actor Registrants Act of 2020 : report (to accompany H.R. 4806) (includ

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020]- 2020

Drugs and justice seeking a consistent, coherent, comprehensive view

Oxford ; New York : Oxford University Press, 2008. 2008

End Fentanyl Act : report of the Committee on Homeland Security and Governmental Affairs, United Sta

United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs, author.
Washington : U.S. Government Publishing Office, 2023. 2023

An expiration date for temporary control of fentanyl analogues

Lampe, Joanna R., author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020] 2020

FDA Amendments Act of 2007 (P.L. 110-85)

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA regulation of follow-on biologics

Johnson, Judith A. (Judith Ann), 1957- author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

FDA a history

[Los Angeles] : Choices, [2010] 2010

Federal drug offenses departures from sentencing guidelines and mandatory minimum sentences, fiscal

United States. General Accounting Office.
[Washington, D.C.] : U.S. General Accounting Office, [2003] 2003

Food and Drug Administration Reform Act of 2012 : report (to accompany H.R. 5651) (including cost es

United States. Congress. House. Committee on Energy and Commerce.
[Washington, D.C. : U.S. G.P.O., 2012] 2012

Halt All Lethal Trafficking of Fentanyl Act : report together with minority views (to accompany H.R.

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2023] 2023

High intensity drug trafficking areas (HIDTA) Program

Finklea, Kristin M., author.
[Washington, D.C.] : Congressional Research Service, 2021- 2021

Illicit fentanyl and weapons of mass destruction : international controls and policy options

Kerr, Paul K., author.
[Washington, D.C.] : Congressional Research Service, 2022- 2022

Is impossibility preemption impossible? : federal drug law and preemption of state tort claims

Armstrong, Kathryn B., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate,

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Legal handbook for pharmacy technicians

Darvey, Diane L.
Bethesda, Md. : American Society of Health-System Pharmacists, 2008. 2008

Listed chemicals and federal regulation of controlled substance precursors.

Lampe, Joanna R., author.
[Washington, D.C.] : Congressional Research Service, 2023- 2023

Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce.

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]- 2019

"Medical" marijuana, federal drug law, and the constitution's supremacy clause : hearing before the

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2001. 2001

Medical Marijuana Research Act : report (to accompany H.R. 3797).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020]- 2020

Medical product innovation and regulation : benefits and risks

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Medical product innovation and regulation: benefits vs. risks

Johnson, Judith A. (Judith Ann), 1957- author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Medical product regulation : drugs, biologics, and devices

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Opioid treatment programs and related federal regulations

Duff, Johnathan H., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Pain Relief Promotion Act : hearing before the Committee on the Judiciary, United States Senate, One

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office], 2001. 2001

Prescription Drug User Fee Act (PDUFA): 2012 reauthorization as PDUFA V

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Prescription drugs strategic framework would promote accountability and enhance efforts to enforce t

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Government Accountability Office, [2005] 2005

Preserve Access to Affordable Generics Act report together with minority views (to accompany S. 369)

United States. Congress. Senate. Committee on the Judiciary.
[Washington, D.C.] : [U.S. G.P.O.], [2010] 2010

The Proposed Drug Quality and Security Act (H.R. 3204)

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2020- 2020

Protecting Patient Access to Emergency Medications Act of 2016 : report (to accompany H.R. 4365).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2016]- 2016

Reauthorization of PDUFA what it means for jobs, innovation, and patients : hearing before the Subco

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2012. 2012

Regulation of over-the-counter (OTC) drugs

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Regulatory exclusivity reform in the 115th Congress

Thomas, John R., 1967- author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

S. 334 : an approach to drug importation : hearing of the Committee on Health, Education, Labor, and

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005. 2005

Safe Doses Act, the Counterfeit Drug Penalty Enhancement Act of 2011, and the Foreign Counterfeit Pr

United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2012. 2012

Safe Drug Disposal Act of 2010 : report (to accompany H.R. 5809) (including cost estimate of the Con

United States. Congress. House. Committee on Energy and Commerce.
[Washington, D.C.] : [U.S. G.P.O.], [2010] 2010

Safeguarding Therapeutics Act : report (to accompany H.R. 5663).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2020] 2020

Specialty drugs : background and policy concerns

Kirchhoff, Suzanne M., author.
[Washington, D.C.] : Congressional Research Service, [2018?]- 2018

State Rewards Program Update and Technical Corrections Act of 2012 : report (to accompany S. 2318).

United States. Congress. Senate. Committee on Foreign Relations, author.
[Washington, D.C.] : [U.S. Government Printing Office], [2012] 2012

Synthetic Opioid Danger Awareness Act : report (to accompany H.R. 2364).

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2021] 2021